Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29895542)

  • 1. Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.
    Martins A; Gonçalves A; Almeida T; Midões A
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
    Chen SW; Chen YK
    World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
    Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
    Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
    J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medullary thyroid carcinoma].
    Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
    Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
    Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
    BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.
    Murphy DC; Johnson SJ; Aspinall S
    Ann R Coll Surg Engl; 2020 Mar; 102(3):e63-e66. PubMed ID: 31841033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of PET/CT with
    Romero-Lluch AR; Cuenca-Cuenca JI; Guerrero-Vázquez R; Martínez-Ortega AJ; Tirado-Hospital JL; Borrego-Dorado I; Navarro-González E
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2004-2013. PubMed ID: 28646462
    [TBL] [Abstract][Full Text] [Related]  

    Yang JH; Camacho CP; Lindsey SC; Valente FOF; Andreoni DM; Yamaga LY; Wagner J; Biscolla RPM; Maciel RMB
    Endocr Pract; 2017 Aug; 23(8):942-948. PubMed ID: 28614009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of medullary thyroid cancer in the prediction of cure after thyroidectomy.
    Nien FJ; Chang TC
    J Formos Med Assoc; 2015 Sep; 114(9):793-4. PubMed ID: 23906686
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
    Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature.
    Appetecchia M; Barnabei A; Pompeo V; Sentinelli S; Baldelli R; Corsello SM; Torino F
    BMC Endocr Disord; 2014 Oct; 14():84. PubMed ID: 25306429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Challenges of Medullary Thyroid Carcinoma.
    Leimbach RD; Hoang TD; Shakir MKM
    Oncology; 2021; 99(7):422-432. PubMed ID: 33878761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
    Trimboli P; Guidobaldi L; Bongiovanni M; Crescenzi A; Alevizaki M; Giovanella L
    Diagn Cytopathol; 2016 Jan; 44(1):45-51. PubMed ID: 26481456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
    Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
    Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rising CEA levels in a patient with colon carcinoma: metachronous medullary thyroid cancer.
    Göksu SS; Göksu UA; Gündüz S; Coskun HS
    Int J Biol Markers; 2014 Jun; 29(2):e184-6. PubMed ID: 24425322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
    Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
    BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.
    Thomas CM; Asa SL; Ezzat S; Sawka AM; Goldstein D
    Curr Oncol; 2019 Oct; 26(5):338-344. PubMed ID: 31708652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.